|
Eryc 125Drug - Eryc 125 The trade name of the product as shown on the labeling.
Dosage -
CAPSULE, DELAYED REL PELLETS; ORAL
Active Ingredient(s) -
Erythromycin
Strength -
125MG
Applicant -
PARKE DAVIS
New Drug Application (NDA) Number -
062648
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Oct 24, 1985
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Parke Davis Div Warner Lambert Co
Eryc 125
Invanz Eq 1gm Base/vial Injectable; Intramuscular, Iv (infusion)
Eryc 250mg Capsule, Delayed Rel Pellets; Oral Eryc 250mg Capsule, Delayed Rel Pellets; Oral Eryc 250mg Capsule, Delayed Rel Pellets; Oral Eryc 250mg Capsule, Delayed Rel Pellets; Oral Eryc 125 125mg Capsule, Delayed Rel Pellets; Oral Wigrettes 2mg Tablet; Sublingual Tarceva Eq 100mg Base Tablet; Oral Tarceva Eq 150mg Base Tablet; Oral Tarceva Eq 25mg Base Tablet; Oral NewDrugInformation |